| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Former Chief Executive Officer | Chief Executive Officer
3 companies
Joseph Fralin Woody is Former Chief Executive Officer at AVNS, with reported holdings spanning 3 companies. Joseph Fralin Woody's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $8.1M at current prices.
Our model assigns Joseph Fralin Woody a strong insider score of 71/100, based on 4 past trades. On a 3-month view, all 4 of the rated trades came out ahead, averaging +100.0% over three months.
Joseph Fralin Woody's largest disclosed position is in AVNS as Former Chief Executive Officer, worth about $6.2M. Net of sales, the AVNS filings show accumulation of 7,000 shares.
Joseph Fralin Woody has 23 Form 4 filings on record from June 2017 to June 2026, across 3 companies: Director at AVITA Medical (RCEL), 2026; Director at AVITA Medical (AVHHL), 2026; Former Chief Executive Officer at Avanos Medical (AVNS), 2017–2025.
The 40 reported transactions were 13 tax withholdings, 11 open-market purchases, 8 stock awards and 6 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 6 purchases worth about $480K and no sales.
The largest open-market purchase was 3,500 shares of AVNS at an average $43.35 on November 28, 2018, about $152K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | RCEL Avita Medical, Inc. | Director | Buy | 10,000 | $4.19 | $41,900.00 | +10.8% | +152.7% | - | |
| Jun 9, 2026 | AVHHL Avita Medical, Inc. | Director | Buy | 5,200 | $4.00 | $20,800.00 | +5.1% | - | - | |
| Jun 3, 2026 | RCEL Avita Medical, Inc. | Director | Buy | 10,000 | $4.09 | $40,949.00 | +12.1% | +142.1% | - | |
| Jun 2, 2026 | RCEL Avita Medical, Inc. | Director | Buy | 20,000 | $4.25 | $84,936.50 | New | +141.1% | - | |
| May 30, 2019 | AVNS Avanos Medical, Inc. | Chief Executive Officer | Buy | 3,500 | $39.95 | $139,825.00 | +14.0% | - | - | |
| Nov 28, 2018 | AVNS Avanos Medical, Inc. | Chief Executive Officer | Buy | 3,500 | $43.35 | $151,725.00 | +16.2% | - | - |